Owner Alexion Pharmaceuticals, Inc.

Inventors Springhorn, Jeremy P.; Gies, David

Agent Shelston IP

Pub. Number AU-A-2010218277

PCT Pub. Number WO2010/099019

Priority 61/208,487 24.02.09 US

Filing date 18 February 2010

Wipo publication date 2 September 2010

C07K 19/00 (2006.01) Hybrid peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

C07K 14/505 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/70 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine